Trial Profile
Transition from intramuscular ziprasidone to oral formulation in agitated inpatients with acute exacerbation of schizophrenia: A 7+N days, open-labeled, single-arm, multicenter and prospective study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2016
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Ziprasidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 26 Apr 2016 New trial record